medigraphic.com

2006, Number 3

<< Back Next >>

Cir Cir 2006; 74 (3)

Thrombotic microangiopathy and intravascular hemolysis in pregnancy-induced hypertension. The lie of HELLP syndrome

Díaz de León-Ponce MA, Briones-Garduño JC, Meneses-Calderón J, Moreno-Santillán AA

Language: Spanish
References: 46
Page: 211-215
PDF size: 133.17 Kb.


ABSTRACT

We reviewed the literature regarding pregnancy-induced hypertension and its relation with thrombotic microangiopathy and intravascular hemolysis (TMIH). In the present work we described the background, frequency, mortality, clinical picture, classification, diagnosis, complications and treatment. In addition, we analyzed Weinstein’s report of 1982, and we concluded that the reported data of the HELLP syndrome is not conclusive because the presence of TMIH is not demonstrable in his group of patients. Also, we retrospectively reviewed the medical charts from three Intensive Care Units from two specialized gynecoobstetrics hospitals and from one General Hospital. From all the patients with pregnancy-induced hypertension and who developed TMIH confirmed clinically and by laboratory findings, we described the incidence of acute renal failure and the mortality in this group of patients.


REFERENCES

  1. 1.Symers WSTC. Thrombotic microangiopathic haemolytic anaemia. Br Med J 1952;2:897-903.

  2. 2.Bull BS, Rubenberg ML, Dacie JV, Brain MC. Microangiopathic haemolytic anaemia: experimental production of fragmented erythrocytes in vitro. Br J Haematol 1968;3:322-323.

  3. 3.Kwaan HC. Miscellaneous secondary thrombotic microangiopathy. Semin Hematol 1987;243:141-147.

  4. 4.Okafor UV, Efetie RE. Acute renal failure due to HELLP syndrome and acute renal failure in mid-gestation. Int J Obstet Anesth 2005; 14:265-268.

  5. 5.Martínez J. Microangiophatic hemolytic anemia. In: Beutler E, Marshall A, Lichtman M, Barry S, Coller MO, Thomas JK, eds. Hematology. Philadelphia: Williams & Wilkins;1997.

  6. 6.Díaz de León PM, Briones GJC, Espinosa MML. Microangiopatía trombótica y hemólisis intravascular en la preeclampsia-eclampsia. En: Aguirre GH, editor. Actualidades médico-quirúrgicas 1. México: Editorial Prado;1999. pp. 147-153.

  7. 7.Pritchard JA, Ratnoff OD, Wesisman R Jr. Hemostatic defects and increased red cell destruction in pre-eclampsia and eclampsia. Obstet Gynecol 1954;2:159-164.

  8. 8.López Llera MM, Espinosa MM, Díaz de León PM, Rubio LC. Abnormal coagulation and fibrinolysis in eclampsia. Am J Obstet Gynecol 1976;124:681-687.

  9. 9.Díaz de León PM, Vargas SLB, Espinosa MM, Martínez GM. Insuficiencia renal aguda, anemia hemolítica y trombocitopenia en toxemia del embarazo. Nefrología Mex 1981;1:5-12.

  10. 10.Espinosa MM, Díaz de León PM, Yánez MI, Neniger CHJH, Colmenares MI. Microangiopatía trombótica y hemólisis intravascular en la toxemia. Rev Med IMSS 1982;20:35-41.

  11. 11.Weinstein L. Syndrome of hemolysis, elevated liver enzymes and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 1982;159-167.

  12. 12.Weinstein L. It has been a great ride: the history of HELLP syndrome. Am J Obstet Gynecol 2005;193(3 Pt 1):860-863.

  13. 13.Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989;161:1200-1204.

  14. 14.López-Llera MM. Recurrent eclampsia. Clinical data, morbidity and pathogenic considerations. Eur J Obstet Gynecol Reprod Biol 1993;50:9-45.

  15. 15.Dekker GA, Van Geijn H. Endothelial dysfunction in preeclampsia. 1. Primary prevention: therapeutic perspectives. J Perinatol Med 1996;24:99-117.

  16. 16.Dekker CA, Van Geijn H. Endothelial dysfunction in preeclampsia. 11. Reducing the adverse consequences of endothelial cell dysfunction in preeclampsia: therapeutic perspectives. J Perinatol Med 1996;24:119-139.

  17. 17.Williams OJ, Swiet M. The pathophysiology of preeclampsia-eclampsia. Intensive Care Med 1997;23:620-629.

  18. 18.Spargo B, McCartney CP, Winemiller R. Glomerular capillary endotheliosis in toxemia of pregnancy. Arch Pathol 1959;68:593-599.

  19. 19.Díaz de León PM, Espinosa MM, Briones CJC, López-Llera MM, Briones VCC. Microangiopatía trombótica y hemólisis intravascular en preeclampsia-eclampsia. Los eslabones perdidos en el síndrome de HELLP. Rev Med Asoc Mex Med Crit Ter Int 1997;1:4-8.

  20. 20.Meneses CJ, Figueroa FMR, Mejía ML, Jiménez VO. Síndrome de HELLP. Gac Med Inst Sal Edo Mex 1993;3:682-690.

  21. 21.Vargas HVM, Romo VLM, Oros RJA. Síndrome de HELLP: presentaci0ón de un caso y revisión de la literatura. Ginecol Obstet Mex 1991;59:225-228.

  22. 22.Rodríguez-González D, Velarde Ibarra R. Severe pre-eclampsia and HELLP syndrome. Ginecol Obstet Mex 1994;62:325-329.

  23. 23.Zetina THJ, Pizano ME. Falla renal aguda en pacientes toxémicas con síndrome de HELLP. Rev Asoc Mex Med Crit Ter Int 1995; 4:107-110.

  24. 24.Argueta ZM, Neri MC, Lira PJ, Ibarguengoitia F, Vázquez JME. Síndrome de HELLP, siete años de experiencia en el Instituto Nacional de Perinatología. Ginecol Obstet Mex 1995;63:217-221.

  25. 25.Martin JN, Blake PC, Lowry SL, Ferry KG, Files JC. Pregnancy complicated by preeclampsia-eclampsia with the hemolysis, elevated liver enzymes, and low platelet count: postparturn recovery? Obstet Gynecol 1990;76:737-741.

  26. 26.Sibai BM. The HELLP syndrome (hemolysis, elevated liver enzymes and low platelets): much ado about nothing? Am J Obstet Gynecol 1990;62:311-316.

  27. 27.Wilke G, Rath W, Schutz E, Armstrong VW, Kuhn W. Haptoglobin as a sensitive marker of hemolysis in HELLP-syndrome. Int J Gynaecol Obstet 1992;1:29-34.

  28. 28.Neiger R, Contag SA, Coustan DR. The resolution of preeclampsia related thrombocytopenia. Obstet Gynecol 1991;77:692-695.

  29. 29.Guntupalli SR, Steingrub J. Hepatic disease and pregnancy: an overview of diagnosis and management. Crit Care Med 2005;33(10 Suppl):S332-S339.

  30. 30.O’Brien JM, Barton JR. Controversies with the diagnosis and management of HELLP syndrome. Clin Obstet Gynecol 2005;48:460-477.

  31. 31.Van Dam PA, Renier M, Baekelandt M, Buytaert P, Uyttenbroeck F. Disseminated intravascular coagulation and the syndrome of hemolysis, elevated liver enzymes, and low platelet in severe preeclampsia. Obstet Gynecol 1989;73:97-101.

  32. 32.Briones GJC, Zamora GM. Tratamiento de la toxemia gravídica (preeclampsia eclampsia). Acta Med 1994;33:47-52.

  33. 33.Briones GJC, González AR. Isoxuprina en la hipertensión del embarazo. Gac Med Mex 1997;5:403-406.

  34. 34.López-Llera MM, Espinosa MML, Arratia SC. Eclampsia and placental abruption: basic patterns, management and morbidity. J Gynecol Obstet 1988;27:335-342.

  35. 35.Nguyen TC, Stegmayr B, Busund R, et al. Plasma therapies in thrombotic syndromes. Int J Artif Organs 2005;28:459-465.

  36. 36.Schwartz M. Do gravid women with preeclampsia-eclampsia ever require plasmapheresis? Am J Obstet Gynecol 1997;176:1397-1398.

  37. 37.O’Brien JM, Poynter L, Barton JR. Transfusion for hemolysis, elevated liver function tests, and low platelet count in pregnancy. Int J Gynaecol Obstet 2005;89:291-292.

  38. 38.Síbai BM, Raniadam MK. Acute renal failure in pregnancies complicated by hemolysis, elevated liver enzymes, and low platelets. Am J Obstet Gynecol 1993;168:1682-1690.

  39. 39.Briones GJC, Castañón GJA, Díaz de León PM, Briones VCG. La Unidad de Cuidados Intensivos Multidisciplinaria y la Medicina Crítica en Gineco-Obstetricia. Rev Asoc Mex Med Crit Ter Int 1996;6:276-279.

  40. 40.Díaz de León PM, Briones GJC, Kably AA, Barrón VJ, Espinosa MM, Juárez AG. Medicina crítica en obstetricia. Rev Asoc Mex Med Crit Ter Int 1997;2:36-40.

  41. 41.Briones GJC, Castañón GJA, Díaz de León PM, Madrazo NI, Deseano EJL, Briones VCG, et al. Hemodinamia cerebral en embarazo normal y en preeclampsia eclampsia. Rev Asoc Mex Med Crit Ter Int 1997;4:106-111.

  42. 42.Velasco MV, Navarrete HE, Cardona PJA, Madrazo NM. Mortalidad materna por preeclampsia-eclampsia en el Instituto Mexicano del Seguro Social 1987-1996. Rev Med IMSS 1997;6:451-456.

  43. 43.Van Pampus MG, Aarnoudse JG. Long-term outcomes after preeclampsia. Clin Obstet Gynecol 2005;48:489-494.

  44. 44.Celik C, Gezginc K, Altintepe L, et al. Results of the pregnancies with HELLP syndrome. Renal Fail 2003;25:613-618.

  45. 45.Deruelle P, Coudoux E, Ego A, et al. Risk factors for post-partum complications occurring after preeclampsia and HELLP syndrome. A study in 453 consecutive pregnancies. Eur J Obstet Gynecol Reprod Biol 2005;125:59-65.

  46. 46.Altamura C, Vasapollo B, Tibuzzi F, et al. Postpartum cerebellar infarction and haemolysis, elevated liver enzymes, low platelet (HELLP) syndrome. Neurol Sci 2005;26:40-42.




2020     |     www.medigraphic.com